Jeffrey Harding

Title: Innovations by Jeffrey Harding in Immunomodulatory Cells

Introduction

Jeffrey Harding is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of immunology, particularly in the development of immunomodulatory cells. With a total of 2 patents, his work focuses on enhancing allograft tolerance without the need for systemic immune suppression.

Latest Patents

One of his latest patents is titled "IMMUNOMODULATORY CELLS AND USES THEREOF." This invention provides a method for achieving allograft tolerance through a genetically modified cell that offers local immunosuppression at a transplant site. The cell is designed to mitigate various immune responses, including the activation of antigen-presenting cells and the activity of graft-attacking leukocytes. This innovative approach aims to improve transplant outcomes by reducing the need for systemic immune suppression.

Career Highlights

Jeffrey Harding is currently associated with Sinai Health System, where he continues to advance his research in immunology. His work has the potential to transform transplant medicine by providing safer and more effective methods for managing immune responses.

Collaborations

He collaborates with esteemed colleagues, including Andras Nagy and Kristina Nagy, who contribute to his research endeavors.

Conclusion

Jeffrey Harding's innovative work in immunomodulatory cells represents a significant advancement in the field of transplant medicine. His patents reflect a commitment to improving patient outcomes through cutting-edge research and collaboration.